UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044839
Receipt number R000051214
Scientific Title A prospective study of various functional assessments of the elderly and adverse events, persistence, and treatment effects of cancer chemotherapy
Date of disclosure of the study information 2021/08/01
Last modified on 2021/07/13 09:08:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Survey on Functional Assessment and Cancer Chemotherapy in the Elderly

Acronym

Physical Fitness and Adverse Effects of Cancer Chemotherapy in the Elderly

Scientific Title

A prospective study of various functional assessments of the elderly and adverse events, persistence, and treatment effects of cancer chemotherapy

Scientific Title:Acronym

A Prospective Study on Functional Assessment and Cancer Chemotherapy Practice in the Elderly

Region

Japan


Condition

Condition

malignant tumor

Classification by specialty

Gastroenterology Hepato-biliary-pancreatic medicine Pneumology
Hematology and clinical oncology Nephrology Surgery in general
Gastrointestinal surgery Hepato-biliary-pancreatic surgery Chest surgery
Breast surgery Obstetrics and Gynecology Dermatology
Oto-rhino-laryngology Orthopedics Urology
Oral surgery Neurosurgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This study will conduct functional assessment of the elderly in patients with malignant tumors undergoing chemotherapy to investigate the impact of chemotherapy on side effects and treatment outcomes.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

To investigate the functional assessment of the elderly and the incidence of side effects during the first 6 months of treatment. Elderly functional assessment will evaluate VES13, cognitive function, such as G8

Key secondary outcomes

Type of side effect, reason for dose reduction, relative dose intensity


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients undergoing first-line chemotherapy or first-line.
recurrent chemotherapy for solid cancer
Patients with Eastern Cooperative Oncology Group Performance Status 4.
Patients for whom free and voluntary consent to participate in research can be obtained in writing from the individual.
Patients aged 18 years or older at the time of obtaining consent.

Key exclusion criteria

Patients with CTCAE grade 2 or higher side effects prior to chemotherapy administration.
Patients who are unable to properly complete the elderly functional assessment chart(dementia, etc.)
If a family member who lives with the respondent can answer the question, the respondent is not excluded.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Junya
Middle name
Last name Sato

Organization

International University of Health and Welfare Hospital

Division name

Department of Pharmacy

Zip code

329-2763

Address

537-3,Iguchi,Nasushiobara-shi,Tochigi,329-2763 Japan

TEL

0287-37-2221

Email

junya.sato@iuhw.ac.jp


Public contact

Name of contact person

1st name Manami
Middle name
Last name Kazaoka

Organization

International University of Health and Welfare Hospital

Division name

Department of Pharmacy

Zip code

329-2763

Address

537-3,Iguchi,Nasushiobara-shi,Tochigi,329-2763 Japan

TEL

0287-37-2221

Homepage URL


Email

21p2001@g.iuhw.ac.jp


Sponsor or person

Institute

International University of Health and Welfare Hospital

Institute

Department

Personal name



Funding Source

Organization

International University of Health and Welfare Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

International University of Health and Welfare Hospital

Address

537-3,Iguchi,Nasushiobara-shi,Tochigi,329-2763 Japan

Tel

0287-37-221

Email

junya.sato@iuhw.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 07 Month 13 Day

Date of IRB

2021 Year 08 Month 01 Day

Anticipated trial start date

2021 Year 08 Month 01 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry

2023 Year 01 Month 31 Day

Date trial data considered complete

2023 Year 01 Month 31 Day

Date analysis concluded

2023 Year 03 Month 31 Day


Other

Other related information

This study is a prospective observational study that will accept entries until December 31, 2023.


Management information

Registered date

2021 Year 07 Month 13 Day

Last modified on

2021 Year 07 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051214